Docket Room.
SB 387·OH·senate

Regards Medicaid managed care coverage of pharmacogenomic testing

In CommitteeFiled Mar 23, 2026
Sponsor: Louis W. Blessing, III (R)
Latest Action

Refer to Committee

Mar 25, 2026

Email me when SB 387 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track SB 387. By continuing you agree to the Terms and Privacy Policy.

Legislative status

  1. Introduced
  2. In Committee
  3. Reported by Committee
  4. Floor Vote Scheduled
  5. Passed One Chamber
  6. Passed Both Chambers
  7. Sent to Executive
  8. Signed into Law

Summary

The bill directs Medicaid managed care organizations to cover genetic tests that assess how a patient’s genes affect drug safety and effectiveness when treating depression or anxiety, provided a prescriber orders the test and it meets Medicare local coverage criteria. It also sets limits on prior‑authorization requirements and creates penalties for organizations that fail to follow the new rules.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about SB 387

3 free questions a day, no account

Hearings

History

  1. Referred to committee
  2. Introduced

Sponsors

  • Louis W. Blessing, III (R) · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when SB 387 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track SB 387 free

Or ask your AI assistant about SB 387 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice